TickerFactsScreenerDevelopers

Immunome Inc. (IMNM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $2.54M2020: $39.77M2021: $49.23M2022: $20.32M2023: $98.68M2024: $143.35M2025: $653.48M$653.48M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$653.48M+355.9%
2024$143.35M+45.3%
2023$98.68M+385.6%
2022$20.32M-58.7%
2021$49.23M+23.8%
2020$39.77M+1463.7%
2019$2.54M—